Inventor · New Hope, PA, US

Hung V. Do

32Patents
8h-index
16Co-inventors
72Inventor score

Filing activity: Aug 4, 2000 → Mar 21, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8592362B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 53 Active
US9095584B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 50 Active
US9545397B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 48 Active
US9206457B2 Utilization of pharmacological chaperones to improve manufacturing and purification of biologics Chemistry; Metallurgy 48 Active
US10813921B2 Method to predict response to pharmacological chaperone treatment of diseases Physics 37 Active
USRE48608E1 Method to predict response to pharmacological chaperone treatment of diseases General 35 Active
US9545450B2 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases Chemistry; Metallurgy 14 Active
US10512676B2 Formulations comprising recombinant acid alpha-glucosidase Chemistry; Metallurgy 10 Active
US6517830B1 Compositions and methods for the expression of factor VIII polypeptides and uses therefor Human Necessities 8 Expired
US10857212B2 Augmented acid alpha-glucosidase for the treatment of Pompe disease Chemistry; Metallurgy 7 Active
US10208299B2 Highly potent acid alpha-glucosidase with enhanced carbohydrates Chemistry; Metallurgy 7 Active
US10227577B2 Method for selection of high M6P recombinant proteins Human Necessities 7 Active
US10961522B2 Highly potent acid alpha-glucosidase with enhanced carbohydrates Chemistry; Metallurgy 5 Active
US9279007B2 Signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins Chemistry; Metallurgy 4 Active
US10874750B2 Gene therapy constructs and methods of use Chemistry; Metallurgy 3 Active
US11491211B2 Formulations comprising recombinant acid alpha-glucosidase Chemistry; Metallurgy 3 Active
US11591583B2 Highly potent acid alpha-glucosidase with enhanced carbohydrates Chemistry; Metallurgy 3 Active
US11753632B2 Highly potent acid alpha-glucosidase with enhanced carbohydrates Chemistry; Metallurgy 3 Active
US11491243B2 Gene therapy constructs and methods of use Chemistry; Metallurgy 2 Active
US11278601B2 Augmented acid alpha-glucosidase for the treatment of Pompe disease Chemistry; Metallurgy 2 Active
US10660972B2 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases Chemistry; Metallurgy 1 Active
US12246062B2 Recombinant human acid alpha-glucosidase Chemistry; Metallurgy 0 Active
US9821038B2 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity Chemistry; Metallurgy 0 Active
US9889203B2 Chemical crosslinkers Chemistry; Metallurgy 0 Active
US9254313B2 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.